In a report released on March 27, David Roman from Goldman Sachs maintained a Hold rating on Healthequity (HQY – Research Report), with a price ...

HQY stock wiped out its Trump election rally as the health savings account leader's earnings missed on elevated fraud costs.

Wednesday’s 10 Worst Performers. In this article, we are going to take a look at where HealthEquity Inc. (NASDAQ:HQY) stands ...

HealthEquity (NASDAQ:HQY – Free Report) had its price objective trimmed by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday morning,Benzinga reports. The firm currently ...

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,618.59 today based on a ...

HealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Tuesday, MarketBeat.com ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

In its fourth quarter 2024 investor letter, Wasatch Long/Short Alpha Fund emphasized stocks such as HealthEquity, Inc. (NASDAQ:HQY). HealthEquity, Inc. (NASDAQ:HQY) provides financial technology ...